EUVIMEDEUVIMED entdecken
Crossref

Association between PAI-1 4G/5G genotype and residual thrombus in acute mesenteric venous thrombosis

Bin Liu, Hai Feng, Wenrui Li

Molecular Biology Reports · 2024-12 · 51 (1)

DOI: 10.1007/s11033-024-09947-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 20.09.2024. Verfasst von Bin Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China. Hauptthemen laut MEDLINE: Plasminogen Activator Inhibitor 1, Venous Thrombosis, Genotype. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Beijing Friendship Hospital Seed Project, Capital Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Plasminogen activator inhibitor-1 (PAI-1) is the most important inhibitor of plasminogen activator. The functional 4G/5G polymorphism of the gene coding for PAI-1 may affect PAI-1 plasmatic activity, influencing the imbalance between coagulation and fibrinolysis cascades. In this study, we investigated the association between the PAI-1 4G/5G genotype and the development and residual thrombus of acute primary mesenteric venous thrombosis (MVT). METHODS: The clinical data of 34 patients who underwent acute primary MVT were retrospectively reviewed. Fluorescence in situ hybridization was used to determine if patients had the 4G/5G polymorphism in the promoter of the PAI-1 gene. Patients were stratified according to the genotype of PAI-1. RESULTS: 11 patients (32.3%) were homozygous for the 4G genotype, 23 patients (67.6%) were non-homozygous for the 4G genotype (5G/5G). The extent of thrombosis was not correlated with the PAI-4G/5G polymorphism. After a mean follow-up of 16.6 ± 10.4 months, the 4G/4G genotype had a significantly larger thrombus burden (p < 0.05). 54% of patients in the 4G/4G genotype group had no lessening in the degree of mesenteric venous thrombosis, significantly higher than other patients (4G/5G + 5G/5G genotypes) (p < 0.05). CONCLUSION: The PAI-1 4G/4G predicts residual thrombus of mesenteric veins after the acute phase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasminogen Activator Inhibitor 1Venous ThrombosisGenotypeHumansMaleFemaleMiddle AgedAdultRetrospective StudiesMesenteric VeinsAgedPolymorphism, GeneticAcute DiseasePromoter Regions, GeneticGenetic Predisposition to Disease

Stichwörter der Autor:innen

Acute mesenteric ischemiaAnticoagulantsMesenteric venous thrombosisPlasminogen activator inhibitor 1Thrombolytic therapy

Substanzen

Plasminogen Activator Inhibitor 1SERPINE1 protein, human

Autor:innen und Institutionen

  • Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
  • Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China. li_wenrui@bjmu.edu.cn.

Förderung

  • Beijing Friendship Hospital Seed Project, Capital Medical University

Zitieren

APA

Liu, B., Feng, H., & Li, W. (2024). Association between PAI-1 4G/5G genotype and residual thrombus in acute mesenteric venous thrombosis. Molecular Biology Reports, 51(1). https://doi.org/10.1007/s11033-024-09947-y

Vancouver

Liu B, Feng H, Li W. Association between PAI-1 4G/5G genotype and residual thrombus in acute mesenteric venous thrombosis. Molecular Biology Reports. 2024;51(1). doi:10.1007/s11033-024-09947-y

BibTeX
@article{Liu2024,
  author = {Liu, Bin and Feng, Hai and Li, Wenrui},
  title = {Association between PAI-1 4G/5G genotype and residual thrombus in acute mesenteric venous thrombosis},
  journal = {Molecular Biology Reports},
  year = {2024},
  volume = {51},
  number = {1},
  doi = {10.1007/s11033-024-09947-y}
}
Kostenlos starten →